Health product recall

POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient

Last updated

Summary

Product
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION
Issue
Health products - Labelling
What to do

See instructions below. 

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

Potassium Chloride in Lactated Ringer’s Injection USP

Potassium Chloride in Lactated Ringer’s Injection USP

DIN 02243421

Solution

CALCIUM CHLORIDE 20 MG / 100 ML,
POTASSIUM CHLORIDE 179 MG / 100 ML,
SODIUM CHLORIDE 600 MG / 100 ML, SODIUM LACTATE 310 MG / 100 ML

W2I07A1

Issue

Affected lot is labelled with the incorrect strength and ingredient

 

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers, Healthcare Establishments

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Baxter Corporation

7125 Mississauga Road, Mississauga

ON, L5N 0C2

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-72083

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe